Medications containing Domperidone Should Not be Used in Children under 12 Years Old
ANSM publishes a new warning against domperidone based medicines, because of a “rare but potentially serious cardiac risk”. Attention danger. Medications based on domperidone ( Motilium and generics ) should no longer be administered to children under 12 years, said the National Agency for Medicines ( ANSM ) in a statement released Friday, June 28, 2019. The cause: its adverse effects and in particular a cardiac […]
Continue Reading